121 related articles for article (PubMed ID: 20424476)
1. Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients.
Zhang Q; Li M; Lu Y; Li H; Gu Y; Hao C; Chen J
Nephron Clin Pract; 2010; 115(4):c259-67. PubMed ID: 20424476
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Mason MA; Shepler BM
Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
[TBL] [Abstract][Full Text] [Related]
3. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
[TBL] [Abstract][Full Text] [Related]
4. Ten-year experience with sevelamer and calcium salts as phosphate binders.
Raggi P; Vukicevic S; Moysés RM; Wesseling K; Spiegel DM
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S31-40. PubMed ID: 20089501
[TBL] [Abstract][Full Text] [Related]
5. The effects of non-calcium-based phosphate binders versus calcium-based phosphate binders on cardiovascular calcification and bone remodeling among dialysis patients: a meta-analysis of randomized trials.
Liu L; Wang Y; Chen H; Zhu X; Zhou L; Yang Y
Ren Fail; 2014 Sep; 36(8):1244-52. PubMed ID: 25019348
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
Negri AL
J Nephrol; 2010; 23(6):653-7. PubMed ID: 20349415
[TBL] [Abstract][Full Text] [Related]
7. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
[TBL] [Abstract][Full Text] [Related]
8. Role of sevelamer hydrochloride in the coronary artery calcification score.
Tsuruta Y; Kaneshiro K; Narita Y; Obayashi T; Fujii M; Narita M; Sasai K; Yoshimata T; Watanabe Y; Maeda K
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S22-6. PubMed ID: 16109138
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
Barreto DV; Barreto Fde C; de Carvalho AB; Cuppari L; Draibe SA; Dalboni MA; Moyses RM; Neves KR; Jorgetti V; Miname M; Santos RD; Canziani ME
Nephron Clin Pract; 2008; 110(4):c273-83. PubMed ID: 19001830
[TBL] [Abstract][Full Text] [Related]
10. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. No good evidence to promote a general use of sevelamer.
Nguyen QV; Descombes E
Kidney Int; 2008 Jan; 73(2):238-9, author reply 239. PubMed ID: 18165813
[No Abstract] [Full Text] [Related]
11. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.
Block GA; Spiegel DM; Ehrlich J; Mehta R; Lindbergh J; Dreisbach A; Raggi P
Kidney Int; 2005 Oct; 68(4):1815-24. PubMed ID: 16164659
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi M; Fukagawa M
Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
[TBL] [Abstract][Full Text] [Related]
13. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
[TBL] [Abstract][Full Text] [Related]
14. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
Garg JP; Chasan-Taber S; Blair A; Plone M; Bommer J; Raggi P; Chertow GM
Arthritis Rheum; 2005 Jan; 52(1):290-5. PubMed ID: 15641045
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
16. Low iPTH can predict vascular and coronary calcifications in patients undergoing peritoneal dialysis.
Kim SC; Kim HW; Oh SW; Yang HN; Kim MG; Jo SK; Cho WY; Kim HK
Nephron Clin Pract; 2011; 117(2):c113-9. PubMed ID: 20693812
[TBL] [Abstract][Full Text] [Related]
17. Determinants of progressive vascular calcification in haemodialysis patients.
Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
[TBL] [Abstract][Full Text] [Related]
18. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
Suki WN;
J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
[TBL] [Abstract][Full Text] [Related]
19. Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
Inoue T; Nagatoya K; Kagitani M; Shibahara N; Ueda H; Katsuoka Y; Ohashi S; Kitagawa Y; Nishimoto K; Yasuda H;
Ther Apher Dial; 2007 Jun; 11(3):210-4. PubMed ID: 17498003
[TBL] [Abstract][Full Text] [Related]
20. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
Block GA; Raggi P; Bellasi A; Kooienga L; Spiegel DM
Kidney Int; 2007 Mar; 71(5):438-41. PubMed ID: 17200680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
